1. Vane JR, Flower RJ, Botting RM. History of aspirin and its mechanism of action. Stroke 1990; 21 (12 Suppl.): IV12–23.
2. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs. N Engl J Med 1999; 340: 1888.
3. Балабанова Р.М., Белов Б.С., Чичасова Н.В. и др. Эффективность нимесулида при ревматоидном артрите. Фарматека. 2004; 7: 55–8.
4. Wober W, Rahlfs V, Buchl N et al. Comparative efficacy and safety of the non-steroidal anti-inflammatory drugs nimesulide and diclofenac in patients with acute subdeltoid bursitis and bicipital tendinitis. Int J Clin Pract 1998; 52 (3): 169–75.
5. Facchini R, Selva G, Peretti G. Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fractures. Drugs 1993; 46 (Suppl. 1): 238–41.
6. Binning A. Nimesulide in the treatment of postoperative pain: a double–blind, comparative study in patients undergoing arthroscopic knee surgery. Clin J Pain 2007; 23 (7): 565–70.
7. Pohjolainen T, Jekunen A, Autio L, Vuorela H. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine 2000; 25 (12): 1579–85.
8. Klumb E. The treatment of acute gout arthritis. Double-blind randomized comparative study between nimesulid and indomethacin. Revista Brasileira De Medicine 1996; 53: 540–6.
9. Барскова В.Г., Насонова В.А., Цапина Т.Н. и др. Эффективность и безопасность применения нимесулида (нимесил) у больных подагрическим артритом. Клин. мед. 2004; 12: 49–54.
10. Косарев В.В., Бабанов С.А., Вербовой А.Ф. Справочник клинического фармаколога. Ростов-на-Дону: Феникс, 2011.
11. Sun DC, Roth SH, Mitchell CS et al. Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis 1974; 19: 405–10.
12. Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease: a report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med 1974; 290: 1158–62.
13. Silvoso GR, Ivey KJ, Butt JH et al. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979; 91: 517–20.
14. Насонов Е.Л. Нестероидные противовоспалительные препараты (перспективы применения в медицине). М., 2000.
15. Косарев В.В., Лотков В.С., Бабанов С.А. Клиническая фармакология. Ростов-на-Дону. Феникс, 2008.
16. Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 2004; 18: 790–804.
17. Vane JR. Inhibition of Prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nature 1971; 231: 232–5.
18. Douthwaite AH, Lintott GAM. Gastroscopic observation of effect of aspirin and certain other substances on stomach. Lancet 1938; 2: 1222–5.
19. Miyamoto K, Miyake S, Mizuno M et al. Selective COX-2 inhibitor celecoxib prevents experimental autoimmune encephalomyelitis through COX-2-independent pathway. Brain 2006; 129 (Pt 8): 1984–92.
20. Beata R, Wojciech Н, Stanislaw S, Ryszard M. The influence of anti-inflammatory drugs on the proliferation of fibroblast derived from nasal polyps. Auris Nasus Larynx 2005; 32 (3): 225–9.
21. Suleyman H, Cadirci E, Albayrak A, Halici Z. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug. Curr Med Chem 2008; 15 (3): 278–83.
22. Лазебник Л.Б., Дроздов В.Н. Заболевания органов пищеварения у пожилых. М.: Анахарсис, 2003.
23. Насонов Е.Л., Каратеев А.Е. Поражения желудка, связанные с приемом нестероидных противовоспалительных препаратов. Клин. мед. 2000; 3 (1): 4–10; 4 (2): 4–9.
24. Конорев М.Р., Ковалева Л.Ф. Гастропатия, индуцированная нестероидными противовоспалительными препаратами: факторы риска, лечение, профилактика. Минск, 2006; с. 24–5.
25. Каратеев А.Е., Насонов Е.Л. НПВП-ассоциированная патология ЖКТ: реальное состояние дел в России. РМЖ. 2006; 15: 1073–8.
26. Abdelrahman A, Al Suleimani Y. Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats. Аrch Pharm Res 2008; 31 (12): 1584–9.
27. Huskisson E, Macciocchi A, Rahlfs V et al. Nimesulide versus diclofenac in the treatment of osteoarthritis of the hip or knee: an active controlled equivalence study. Curr Ther Res 1999; 60: 253–65.
28. Traversa G, Bianchi C, Da Cas R et al. Cohort study of hepatotoxity associated with nimesulide and other non-steroidal anti-inflammatory drugs. BMJ 2003; 327: 18–22.
29. European Medicines Evaluation Agency, Committee for Proprietary Medicinal Products. Nimesulide containing medicinal products. CPMP/1724/04. htpp://www.emea.eu.int.
30. Шостак Н.А., Рябкова А.А., Савельев В.С., Малярова Л.Н. Желудочно-кишечное кровотечение как осложнение гастропатий, связанных с приемом нестероидных противовоспалительных препаратов. Тер. арх. 2003; 5: 70–4.
31. Насонов Е.Л., Лазебник Л.Б., Беленков Ю.Н. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: Алмаз, 2006.
32. Pilotto A, Franceschi M, Leandro G et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003; 15 (6): 494–9.
33. Menniti-Ippolito F, Maggini M, Raschetti R et al. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparision with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol 1998; 54: 393–7.
34. Каратеев А.Е. Гастродуоденальная безопасность селективных ингибиторов циклооксигеназы-2: проверка практикой. Тер. арх. 2005; 5: 69–72.
35. Conforti A, Leone R, Moretti U et al. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northen Italian area. Drug Saf 2001; 24: 1081–90.
36. Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in gereral practice. Int J Clin Pract 2004; Suppl. 144: 27–32.
37. Laporte J, Ibanez L, Vidal X et al. Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents. Drug Safety 2004; 27: 411–20.
38. Минушкин О.Н. Использование препарата «Найз» у больных, страдающих сочетанной патологией суставов и поражением верхних отделов желудочно-кишечного тракта. Научо-практ. ревматол. 2003; 5: 72–6.
39. Каратеев А.Е., Каратеев Д.Е., Лучихина Е.Л. и др. Эффективность и безопасность монотерапии высокими дозами НПВП при раннем артрите. РМЖ. 2006; 16: 24–9.
40. Rainsford K. Nimesulide – a multifactorial approach to inflammation and pain: scientific and clinical consensus. Curr Med Res Opin 2006; 22 (6): 1161–70.
41. Boelsterli U. Nimesulide and hepatic adverse affects: roles of reactive metabolites and host factors. Int J Clin Pract 2002; Suppl. 128: 30–6.
42. Boelsterli U. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide. Drug Saf 2002; 25: 633–48.
43. HELSINN’s response. На сайте: HELSINN, 2002, 12. http://www.pharmabiz.com.
44. Helin-Salmivaara A, Virtanen A, Vesalainen R et al. NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 2006; 27 (14): 1657–63.
45. Senna GE, Passalacqua G, Dama A et al. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs. Eur Ann Allergy Clin Immunol 2003; 35 (10): 393–6.
46. Tavares IA, Bishai PM, Bennet A. Activity of nimesulide on constitutive and inducible cyclo-oxygenases. Arzneim-Forsch/Drug Res 1995; 45: 1093–6.
47. Panara MR, Padovano R, Sciulli M et al. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in human beings. Clin Pharmacol Ther 1998; 63: 672–81.

В.В.Косарев, С.А.Бабанов

ГБОУ ВПО Самарский государственный медицинский университет Минздравсоцразвития РФ